Mancuso David J, Han Xianlin, Jenkins Christopher M, Lehman John J, Sambandam Nandakumar, Sims Harold F, Yang Jingyue, Yan Wei, Yang Kui, Green Karen, Abendschein Dana R, Saffitz Jeffrey E, Gross Richard W
Division of Bioorganic Chemistry and Molecular Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Biol Chem. 2007 Mar 23;282(12):9216-27. doi: 10.1074/jbc.M607307200. Epub 2007 Jan 9.
Previously, we identified calcium-independent phospholipase A2gamma (iPLA2gamma) with multiple translation initiation sites and dual mitochondrial and peroxisomal localization motifs. To determine the role of iPLA2gamma in integrating lipid and energy metabolism, we generated transgenic mice containing the alpha-myosin heavy chain promoter (alphaMHC) placed proximally to the human iPLA2gamma coding sequence that resulted in cardiac myocyte-restricted expression of iPLA2gamma (TGiPLA2gamma). TGiPLA2gamma mice possessed multiple phenotypes including: 1) a dramatic approximately 35% reduction in myocardial phospholipid mass in both the fed and mildly fasted states; 2) a marked accumulation of triglycerides during brief caloric restriction that represented 50% of total myocardial lipid mass; and 3) acute fasting-induced hemodynamic dysfunction. Biochemical characterization of the TGiPLA2gamma protein expressed in cardiac myocytes demonstrated over 25 distinct isoforms by two-dimensional SDS-PAGE Western analysis. Immunohistochemistry identified iPLA2gamma in the peroxisomal and mitochondrial compartments in both wild type and transgenic myocardium. Electron microscopy revealed the presence of loosely packed and disorganized mitochondrial cristae in TGiPLA2gamma mice that were accompanied by defects in mitochondrial function. Moreover, markedly elevated levels of 1-hydroxyl-2-arachidonoyl-sn-glycero-3-phosphocholine and 1-hydroxyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine were prominent in the TGiPLA2gamma myocardium identifying the production of signaling metabolites by this enzyme in vivo. Collectively, these results identified the participation of iPLA2gamma in the remarkable lipid plasticity of myocardium, its role in generating signaling metabolites, and its prominent effects in modulating energy storage and utilization in myocardium in different metabolic contexts.
此前,我们鉴定出钙非依赖性磷脂酶A2γ(iPLA2γ)具有多个翻译起始位点以及双重线粒体和过氧化物酶体定位基序。为了确定iPLA2γ在整合脂质和能量代谢中的作用,我们构建了转基因小鼠,其中α-肌球蛋白重链启动子(αMHC)紧邻人类iPLA2γ编码序列放置,导致iPLA2γ在心肌细胞中特异性表达(TGiPLA2γ)。TGiPLA2γ小鼠具有多种表型,包括:1)在进食和轻度禁食状态下,心肌磷脂质量显著降低约35%;2)在短暂热量限制期间,甘油三酯显著积累,占心肌脂质总量的50%;3)急性禁食诱导的血流动力学功能障碍。通过二维SDS-PAGE Western分析,对心肌细胞中表达的TGiPLA2γ蛋白进行生化表征,发现了超过25种不同的同工型。免疫组织化学在野生型和转基因心肌的过氧化物酶体和线粒体区室中鉴定出iPLA2γ。电子显微镜显示,TGiPLA2γ小鼠中存在松散堆积且无序的线粒体嵴,同时伴有线粒体功能缺陷。此外,TGiPLA2γ心肌中1-羟基-2-花生四烯酰基-sn-甘油-3-磷酸胆碱和1-羟基-2-二十二碳六烯酰基-sn-甘油-3-磷酸胆碱水平显著升高,表明该酶在体内产生信号代谢物。总的来说,这些结果确定了iPLA2γ参与心肌显著的脂质可塑性、其在产生信号代谢物中的作用以及在不同代谢背景下对心肌能量储存和利用的显著调节作用。